View Older Stories View More Recent Stories

Jul 7, 2020 08:00AM AbbVie to Host Second-Quarter 2020 Earnings Conference Call
Jun 26, 2020 06:15AM UPDATE: AbbVie (ABBV) Company, Allergan, and Molecular Partners Receive Complete Response Letter from FDA on Biologics License Application for Abicipar pegol
Jun 26, 2020 01:15AM Allergan, an AbbVie Company, and Molecular Partners Receive Complete Response Letter from FDA on Biologics License Application for Abicipar pegol
Jun 23, 2020 07:33AM AbbVie (ABBV) Reports FDA to Review sNDA for IMBRUVICA (ibrutinib); Seeks to Expand U.S. Label with Long-Term Data in Waldenstrom's Macroglobulinemia
Jun 23, 2020 07:30AM IMBRUVICA® (ibrutinib) Seeks to Expand U.S. Label with Long-Term Data in Waldenström's Macroglobulinemia (WM)
Jun 22, 2020 08:00AM AbbVie (ABBV) Announces RINVOQ Monotherapy Shows Improvement in Skin Clearance and Itch in First Phase 3 Study for Atopic Dermatitis
Jun 22, 2020 08:00AM FDA Accepts Supplemental Biologics License Application (sBLA) for BOTOX® (onabotulinumtoxinA) for the Treatment of Pediatric Patients with Neurogenic Detrusor Overactivity
Jun 18, 2020 08:45AM RINVOQ™ (upadacitinib) Monotherapy Shows Improvement in Skin Clearance and Itch in First Phase 3 Study for Atopic Dermatitis
Jun 18, 2020 08:01AM Alpine Immune Sciences (ALPN), AbbVie (ABBV) Announce Option and License Agreement for Development and Commercialization of ALPN-101
Jun 18, 2020 08:00AM Alpine Immune Sciences and AbbVie Announce Option and License Agreement for the Development and Commercialization of ALPN-101
Jun 17, 2020 10:32AM AbbVie Declares Quarterly Dividend
Jun 15, 2020 08:15AM AbbVie (ABBV) Announces FDA Approves JUVEDERM VOLUMA XC for Enhancement of Chin Region
Jun 15, 2020 08:15AM FDA Approves JUVÉDERM® VOLUMA™ XC for Enhancement of the Chin Region
Jun 15, 2020 08:00AM AbbVie to Showcase 27 Studies at the Virtual 2020 Annual Scientific Meeting of the American Headache Society
Jun 13, 2020 02:30AM VENCLEXTA®/VENCLYXTO® (venetoclax) Plus Azacitidine Demonstrates Statistically Significant Overall Survival Benefit and Improved Remission Rates in Treatment-Naïve Acute Myeloid Leukemia Patients
Jun 12, 2020 04:45PM AbbVie Recommends Shareholders Reject TRC Capital's "Mini-Tender" Offer
Jun 12, 2020 03:04PM AbbVie (ABBV) Presents New Late-Breaking Data Showing SKYRIZI Achieves Superior Rates of Complete Skin Clearance Versus COSENTYX at 52 Weeks
Jun 12, 2020 03:02PM AbbVie Presents New Late-Breaking Data Showing SKYRIZI® (risankizumab-rzaa) Achieves Superior Rates of Complete Skin Clearance Versus COSENTYX® (secukinumab) at 52 Weeks
Jun 10, 2020 08:20AM AbbVie (ABBV) Reports Novel Antibody Drug Conjugate ABBV-3373 Shows Improvement in Disease Activity in Phase 2a Study of Patients with RA
Jun 10, 2020 08:15AM Novel Antibody Drug Conjugate ABBV-3373 Shows Improvement in Disease Activity in Phase 2a Study of Patients with Rheumatoid Arthritis
Jun 10, 2020 06:04AM Genmab (GMAB) and AbbVie (ABBV) Announce Broad Oncology Collaboration, Genmab to Receive Upfront Payment of $750M With Total Potential Milestones of Up to $3.15B
Jun 10, 2020 06:00AM Genmab and AbbVie Announce Broad Oncology Collaboration
Jun 10, 2020 06:00AM AbbVie and Genmab Announce Broad Oncology Collaboration
Jun 6, 2020 08:30AM AbbVie Presents Data Showing RINVOQ™ (upadacitinib) Meets Primary and Key Secondary Endpoints in Phase 3 Head-to-Head Study Versus ORENCIA (abatacept) in Rheumatoid Arthritis Patients
Jun 5, 2020 06:04AM AbbVie (ABBV) Enters Collaboration with Harbour BioMed, Utrecht University and Erasmus Medical Center to Develop Monoclonal Antibody Therapy to Prevent & Treat COVID-19
Jun 5, 2020 06:00AM AbbVie, Harbour BioMed, Utrecht University and Erasmus Medical Center Announce Collaboration to Develop Monoclonal Antibody Therapy to Prevent and Treat COVID-19
Jun 5, 2020 06:00AM AbbVie, Harbour BioMed, Utrecht University and Erasmus Medical Center Announce Collaboration to Develop Monoclonal Antibody Therapy to Prevent and Treat COVID-19
Jun 4, 2020 08:32AM AbbVie (ABBV) Announces New Long-term Data from RINVOQ Phase 3 Studies in Rheumatoid Arthritis Presented at EULAR
Jun 4, 2020 08:30AM New Long-term Data from RINVOQ™ (upadacitinib, 15 mg) Phase 3 Studies in Rheumatoid Arthritis Presented at 2020 Annual European E-Congress of Rheumatology (EULAR)
Jun 3, 2020 08:00AM AbbVie to Present at the Virtual Goldman Sachs 41st Annual Global Healthcare Conference
Jun 1, 2020 11:41AM AbbVie (ABBV) Submits Regulatory Applications to FDA and EMA for RINVOQ for Treatment of Adults with Active Psoriatic Arthritis
Jun 1, 2020 11:40AM AbbVie Submits Regulatory Applications to FDA and EMA for RINVOQ™ (upadacitinib) for the Treatment of Adults with Active Psoriatic Arthritis
Jun 1, 2020 08:30AM Allergan Aesthetics Launches Dedicated Multi-Channel Campaign To Contact Patients Who May Not Be Aware Of The BIOCELL® Recall And To Improve Tracking Information For U.S. Breast Implant Patients
Jun 1, 2020 01:00AM AbbVie and Jacobio Announce Strategic Collaboration to Advance SHP2 Inhibitors
May 29, 2020 04:15PM AbbVie (ABBV), Neurocrine (NBIX) Announce FDA Approves First Oral Medication for Management of Heavy Menstrual Bleeding Due to Uterine Fibroids in Pre-menopausal Women
May 29, 2020 04:14PM FDA Approves the First Oral Medication for the Management of Heavy Menstrual Bleeding Due to Uterine Fibroids in Pre-menopausal Women
May 27, 2020 08:30AM AbbVie Presents New Data at the European E-Congress of Rheumatology (EULAR) 2020 Showcasing Depth of its Rheumatology Portfolio
May 27, 2020 08:08AM Ironwood Pharma (IRWD), AbbVie (ABBV) Report Top-Line Phase II Data for MD-7246 in Patients with Abdominal Pain Associated with IBS-D
May 15, 2020 08:30AM AbbVie Data at EHA Annual Congress Highlight Depth and Breadth of Transformative Blood Cancer Portfolio
May 14, 2020 08:00AM AbbVie to Present at the UBS Virtual Healthcare Conference
May 8, 2020 04:17PM AbbVie (ABBV) Completes Acquisition of Allergan (AGN)
May 8, 2020 04:15PM AbbVie Completes Transformative Acquisition of Allergan
May 5, 2020 05:54PM AbbVie (ABBV), Allergan (AGN) Merger Cleared by FTC
May 5, 2020 05:51PM AbbVie and Allergan Receive Clearance from U.S. Federal Trade Commission for AbbVie's Acquisition of Allergan
May 1, 2020 07:43AM AbbVie Reports First-Quarter 2020 Financial Results
Apr 21, 2020 03:23PM AbbVie (ABBV) Announces IMBRUVICA Received 11th FDA Approval
Apr 21, 2020 03:22PM IMBRUVICA® (ibrutinib) Receives 11th FDA Approval
Apr 2, 2020 08:00AM AbbVie to Host First-Quarter 2020 Earnings Conference Call
Mar 31, 2020 07:24PM AbbVie Donates $35 Million for COVID-19 Relief to Support Healthcare Systems, Patients and Communities
Mar 23, 2020 08:03AM AbbVie (ABBV) Announces Positive Topline Results from Phase 3 Trial of VENCLEXTA in Combination with Azacitidine in Patients with AML
View More Recent Stories View Older Stories